Xenon Pharmaceuticals (XENE) EPS (Basic) (2013 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly EPS (Basic) came in at -$1.17 in Q1 2026, down 41.68% year-on-year from -$2.01 in Q1 2025, and up 19.02% on a QoQ basis from -$1.45 in Q4 2025.
Xenon Pharmaceuticals (XENE) EPS (Basic) (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 14 years of EPS (Basic) data on file, last reported at -$1.17 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 41.68% year-over-year to -$1.17 in Q1 2026; TTM through Mar 2026 was -$4.49, a 40.64% decrease from a year earlier, with the FY2025 full-year figure at -$4.48, down 49.01% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.17, up from -$1.45 in the prior quarter.
- Over the last five years, EPS (Basic) for XENE reached as high as -$0.35 in Q1 2022 and fell as low as -$1.45 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.8 across 5 years, with a median of -$0.73 in 2023.
- Across the five-year window, EPS (Basic) advanced 15.23% in 2022 and tumbled 79.78% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$0.62 in 2022, then dropped by 8.35% to -$0.67 in 2023, then retreated by 26.06% to -$0.84 in 2024, then sank by 71.52% to -$1.45 in 2025, then climbed by 19.02% to -$1.17 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.17 in Q1 2026, -$1.45 in Q4 2025, and -$1.15 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Xenon Pharmaceuticals | 5.72 Bn | 5.72 Bn | - | -1.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.17 |
| Dec 31, 2025 | -1.45 |
| Sep 30, 2025 | -1.15 |
| Jun 30, 2025 | -1.07 |
| Mar 31, 2025 | -0.83 |
| Dec 31, 2024 | -0.84 |
| Sep 30, 2024 | -0.81 |
| Jun 30, 2024 | -0.75 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -0.67 |
| Sep 30, 2023 | -0.73 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -0.63 |
| Dec 31, 2022 | -0.62 |
| Sep 30, 2022 | -0.57 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.35 |
| Dec 31, 2021 | -0.57 |
| Sep 30, 2021 | -0.37 |
| Jun 30, 2021 | -0.50 |